{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:50:13Z","timestamp":1786992613830,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jiac.2023.10.024","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T16:02:44Z","timestamp":1699027364000},"page":"352-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Fosfomycin as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia: A case series and review of the literature"],"prefix":"10.1016","volume":"30","author":[{"given":"Keitaro","family":"Omori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuto","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9567-8329","authenticated-orcid":false,"given":"Toshihito","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2771-4309","authenticated-orcid":false,"given":"Yuko","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norifumi","family":"Shigemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Ohge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2023.10.024_bib1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/jac\/dkv368","article-title":"When sepsis persists: a review of MRSA bacteraemia salvage therapy","volume":"71","author":"Kullar","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2023.10.024_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/CMR.00068-15","volume":"29","author":"Falagas","year":"2016","journal-title":"Fosfomycin. Clin Microbiol Rev."},{"key":"10.1016\/j.jiac.2023.10.024_bib3","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3390\/antibiotics9080500","article-title":"Fosfomycin as partner drug for systemic infection management. A systematic review of its synergistic properties from in vitro and in vivo studies","volume":"9","author":"Antonello","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jiac.2023.10.024_bib4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1128\/AAC.32.2.279","article-title":"In vitro activity of LY146032 alone and in combination with other antibiotics against gram-positive bacteria","volume":"32","author":"Debbia","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.10.024_bib5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ja.2014.5","article-title":"In vitro activity of fosfomycin in combination with linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus","volume":"67","author":"Xu-hong","year":"2014","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.jiac.2023.10.024_bib6","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1128\/AAC.06449-11","article-title":"High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis","volume":"56","author":"Mir\u00f3","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.10.024_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02633-17","article-title":"The combination of daptomycin and fosfomycin has synergistic, potent, and rapid bactericidal activity against methicillin-resistant Staphylococcus aureus in a rabbit model of experimental endocarditis","volume":"62","author":"Garc\u00eda-de-la-M\u00e0ria","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.10.024_bib8","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/cid\/ciaa1081","article-title":"Daptomycin plus fosfomycin versus daptomycin alone for methicillin-resistant Staphylococcus aureus bacteremia and endocarditis: a randomized clinical trial","volume":"72","author":"Pujol","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2023.10.024_bib9","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1253\/circj.CJ-19-0549","article-title":"JCS 2017 guideline on prevention and treatment of infective endocarditis","volume":"83","author":"Nakatani","year":"2019","journal-title":"Circ J"},{"issue":"2015","key":"10.1016\/j.jiac.2023.10.024_bib10","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"issue":"625","key":"10.1016\/j.jiac.2023.10.024_bib11","first-page":"e1","article-title":"Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)","volume":"33","author":"Gudiol","year":"2015","journal-title":"Enferm Infecc Microbiol Cl\u00edn"},{"key":"10.1016\/j.jiac.2023.10.024_bib12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jecm.2012.09.007","article-title":"Combination therapy of daptomycin and fosfomycin for vancomycin tolerant methicillin-resistant Staphylococcus aureus endocarditis complicating metastatic osteomyelitis","volume":"4","author":"Teng","year":"2012","journal-title":"J Exp Clin Med"},{"key":"10.1016\/j.jiac.2023.10.024_bib13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2334-11-152","article-title":"High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible Staphylococcus aureus: case report","volume":"11","author":"Chen","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2023.10.024_bib14","first-page":"960","article-title":"Successful management of methicillin-resistant Staphylococcus aureus bacteremia unresponsive to vancomycin by adding fosfomycin: a case report","volume":"95","author":"Linasmita","year":"2012","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.jiac.2023.10.024_bib15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jmii.2013.09.002","article-title":"Vertebral osteomyelitis caused by vancomycin-tolerant methicillin-resistant Staphylococcus aureus bacteremia: experience with teicoplanin plus fosfomycin combination therapy","volume":"49","author":"Lee","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jiac.2023.10.024_bib16","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-0672","article-title":"Successful conservative treatment of mycotic pulmonary artery aneurysms caused by MRSA bacteremia","volume":"144","author":"Iki","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.jiac.2023.10.024_bib17","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/jac\/dkac380","article-title":"In vitro activity of fosfomycin alone and in combination against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid","volume":"78","author":"Saravolatz","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2023.10.024_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113133","article-title":"Efficacy of combined vancomycin and fosfomycin against methicillin-resistant Staphylococcus aureus in biofilms in vivo","volume":"9","author":"Shi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2023.10.024_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01649-21","article-title":"Synergy mechanisms of daptomycin-fosfomycin combinations in daptomycin-susceptible and -Resistant methicillin-resistant Staphylococcus aureus: in vitro, ex vivo, and in vivo metrics","volume":"66","author":"Mishra","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.10.024_bib20","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/AAC.04246-14","article-title":"Daptomycin plus fosfomycin, a synergistic combination in experimental implant-associated osteomyelitis due to methicillin-resistant Staphylococcus aureus in rats","volume":"59","author":"Lingscheid","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.10.024_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6413982","article-title":"Efficacy of linezolid and fosfomycin in catheter-related biofilm infection caused by methicillin-resistant Staphylococcus aureus","volume":"2016","author":"Chai","year":"2016","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jiac.2023.10.024_bib22","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1128\/AAC.02420-12","article-title":"High activity of fosfomycin and rifampin against methicillin-resistant staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model","volume":"58","author":"Mihailescu","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.10.024_bib23","first-page":"2282","article-title":"Combination therapy with rifampicin or fosfomycin in patients with Staphylococcus aureus bloodstream infection at high risk for complications or relapse: results of a large prospective observational cohort","volume":"75","author":"Rieg","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2023.10.024_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/cid\/cir340","article-title":"Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding","volume":"53","author":"Dhand","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2023.10.024_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciz746","article-title":"Daptomycin plus \u03b2-Lactam combination therapy for methicillin-resistant Staphylococcus aureus bloodstream infections: a retrospective, comparative cohort study","volume":"71","author":"Jorgensen","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2023.10.024_bib26","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/AAC.00350-06","article-title":"Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm","volume":"51","author":"Raad","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.10.024_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/cid\/civ808","article-title":"Combination of vancomycin and \u03b2-lactam therapy for methicillin-resistant Staphylococcus aureus bacteremia: a pilot multicenter randomized controlled trial","volume":"62","author":"Davis","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2023.10.024_bib28","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jac\/dkt396","article-title":"Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin","volume":"69","author":"Gasch","year":"2014","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X23002696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X23002696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:07:09Z","timestamp":1761160029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X23002696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1341321X23002696"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2023.10.024","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fosfomycin as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia: A case series and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2023.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}